"Chanel Injection" is the widely-used colloquial name for Filorga NCTF 135HA (New Cellular Treatment Factor), a skin booster injectable containing 59 active components including non-cross-linked hyaluronic acid (HA), 12 vitamins, 23 amino acids, 6 coenzymes, 5 nucleotides, and minerals. The NCTF 135HA formula was developed to support dermal fibroblast activity, collagen synthesis, and skin hydration at the cellular level — simulating the nutrient-rich environment that skin cells require for optimal function.
At Kind Global Clinic Myeongdong, Filorga NCTF 135HA is delivered via the DermaShine Pro automated multi-needle injector (Huons). The DermaShine Pro delivers precise micro-injections of NCTF across the full face using a multi-needle tip, ensuring uniform distribution of the 59-component complex at consistent dermal depth. This automated delivery system reduces injection trauma compared to manual mesotherapy and achieves more uniform coverage than single-point injection techniques.
Both co-directors — Dr. Lee Wonjin (KR Medical License 143124) and Dr. Lee Kangin (KR Medical License 141247) — personally administer all skin booster injections at Kind Global Clinic Myeongdong. There is no delegation to nursing staff. The treating co-director performs the initial skin assessment, selects NCTF concentration and volume based on skin condition, and administers the full DermaShine Pro treatment session.